RXMD - Progressive Care Announces Second Quarter 2020 Quarterly Call and Business Update on August 17th 2020
MIAMI, FL, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ? Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, August 17th, 2020.
In addition, interested parties can submit questions concerning the Company prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: ssmith@smallcapvoice.com by 3:00 PM EST on Monday, August 17th, 2020. Mr. Smith will compile a list of questions and submit them to the Company for consideration prior to the conference call.
To access the call:
Dial-In Number: 1-857-232-0157 Access Code: 422095
For those unable to participate in the live conference call, a replay will be available at https://www.smallcapvoice.com/tag/rxmd/ shortly after the call has concluded. An archived version of the webcast will also be available at https://progressivecareus.com/investor/.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo Rx
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
Five Star RX
https://www.fivestarrx.com/ https://www.facebook.com/fivestarrx/
About Progressive Care Inc.
Progressive Care Inc. (RXMD), through its subsidiaries, is a Florida technology and health services organization that provides prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management. Cautionary Statement Regarding Forward-Looking Statements: Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the Company’s announcement of quarterly results. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Investor Relations Contact:
Armen Karapetyan,
Progressive Care Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcorx.com
For SmallCapVoice.com, Inc. Stuart T. Smith
512-267-2430
ssmith@smallcapvoice.com
www.SmallCapVoice.com